These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 1580643)

  • 41. Incidence and temporal pattern of anorexia, diarrhea, weight loss, and leukopenia in patients with cervical cancer treated with concurrent radiation therapy and weekly cisplatin: comparison with radiation therapy alone.
    Ohno T; Kato S; Wakatsuki M; Noda SE; Murakami C; Nakamura M; Tsujii H
    Gynecol Oncol; 2006 Oct; 103(1):94-9. PubMed ID: 16527337
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Intravenous nedaplatin and intraarterial cisplatin with transcatheter arterial embolization for patients with locally advanced uterine cervical cancer.
    Adachi S; Ogasawara T; Tsubamoto H; Oku H; Hori Y; Tsuji Y; Takemura T; Koyama K
    Int J Clin Pharmacol Res; 2001; 21(3-4):105-10. PubMed ID: 12067139
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [A dose escalation study of concurrent chemoradiation therapy with nedaplatin for cervical cancer].
    Hatae M; Takahashi T; Kodama S; Nakayama H; Kuzuya K; Saji F; Kamiura S; Watanabe Y; Nishimura R; Kono I; Ariyosh Y; Fukuoka M; Imajo Y; Hasegawa K; Noda K; ;
    Gan To Kagaku Ryoho; 2005 Apr; 32(4):473-8. PubMed ID: 15853213
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Phase II study of cis-diammine(glycolato)platinum, 254-S, in patients with advanced germ-cell testicular cancer, prostatic cancer, and transitional-cell carcinoma of the urinary tract. 254-S Urological Cancer Study Group.
    Akaza H; Togashi M; Nishio Y; Miki T; Kotake T; Matsumura Y; Yoshida O; Aso Y
    Cancer Chemother Pharmacol; 1992; 31(3):187-92. PubMed ID: 1334448
    [TBL] [Abstract][Full Text] [Related]  

  • 45. cis-Amminedichloro(2-methylpyridine) platinum(II) (AMD473), a novel sterically hindered platinum complex: in vivo activity, toxicology, and pharmacokinetics in mice.
    Raynaud FI; Boxall FE; Goddard PM; Valenti M; Jones M; Murrer BA; Abrams M; Kelland LR
    Clin Cancer Res; 1997 Nov; 3(11):2063-74. PubMed ID: 9815598
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Dose-escalated paclitaxel in 1-hour infusion with a fixed dose of cisplatin in previously untreated advanced ovarian cancer: a phase II trial of the Spanish Group for Ovarian Cancer.
    Cervantes A; Mendiola C; del Campo JM; Massuti B; Casado A; Escobedo A; Moyano A; Ojeda B; Poveda A; Benito D
    Semin Oncol; 1997 Oct; 24(5 Suppl 15):S15-40-S15-43. PubMed ID: 9346221
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [A phase II study of DWA2114R, a new platinum complex for breast cancer].
    Aoyama H; Kubo K; Uchino J; Hayasaka H; Asaishi K; Izuo M; Ogawa M; Majima H; Yasutomi M; Wada T
    Gan To Kagaku Ryoho; 1992 Jul; 19(7):1033-9. PubMed ID: 1626939
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Nedaplatin].
    Ota K
    Gan To Kagaku Ryoho; 1996 Feb; 23(3):379-87. PubMed ID: 8712835
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A phase I and pharmacokinetic study of diamminecyclobutane-dicarboxylatoplatinum (NSC 241240).
    Curt GA; Grygiel JJ; Corden BJ; Ozols RF; Weiss RB; Tell DT; Myers CE; Collins JM
    Cancer Res; 1983 Sep; 43(9):4470-3. PubMed ID: 6347373
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A Phase 2 trial of the liposomal DACH platinum L-NDDP in patients with therapy-refractory advanced colorectal cancer.
    Dragovich T; Mendelson D; Kurtin S; Richardson K; Von Hoff D; Hoos A
    Cancer Chemother Pharmacol; 2006 Dec; 58(6):759-64. PubMed ID: 16847673
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [A late phase II study of CPT-11 on uterine cervical cancer and ovarian cancer. Research Groups of CPT-11 in Gynecologic Cancers].
    Takeuchi S; Dobashi K; Fujimoto S; Tanaka K; Suzuki M; Terashima Y; Hasumi K; Akiya K; Negishi Y; Tamaya T
    Gan To Kagaku Ryoho; 1991 Aug; 18(10):1681-9. PubMed ID: 1872624
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Phase II study of iproplatin in advanced ovarian carcinoma.
    Sessa C; Vermorken J; Renard J; Kaye S; Smith D; ten Bokkel Huinink W; Cavalli F; Pinedo H
    J Clin Oncol; 1988 Jan; 6(1):98-105. PubMed ID: 3335895
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Phase II study of 5'-DFUR in uterine cervical cancer and ovarian cancer].
    Noda K; Ikeda M; Saito Y; Yajima A; Sato A; Suzuki M; Terashima Y; Ochiai K; Yoshida K; Takada M
    Gan To Kagaku Ryoho; 1991 Dec; 18(15):2557-65. PubMed ID: 1660700
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Carcinomatous meningeosis during cis-platinum treatment of gynaecological cancers (author's transl)].
    Kaufmann M; Zaloumis M; Rabe T; Heinrich D; Kubli F
    Geburtshilfe Frauenheilkd; 1982 Mar; 42(3):166-8. PubMed ID: 6918339
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [A clinical phase III trial of MR-20 in gynecologic nephrotoxicity of cisplatin--a comparative study in MR-20-treated and control patients on cyclical intermittent cisplatin treatment].
    Ochiai K; Ikeda M; Kobayashi H; Nishimura H; Shibasaki T; Sakai O; Oh-hashi Y; Terashima Y
    Gan To Kagaku Ryoho; 1998 Apr; 25(5):713-22. PubMed ID: 9571969
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Phase II study of pirarubicin (THP) in patients with cervical, endometrial and ovarian cancer: study of the Clinical Screening Group of the European Organization for Research and Treatment of Cancer (EORTC).
    Chauvergne J; Fumoleau P; Cappelaere P; Metz R; Armand JP; Chevallier B; Kerbrat P; de Forni M; Lhommé C; Roche H
    Eur J Cancer; 1993; 29A(3):350-4. PubMed ID: 8398333
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Use of chemotherapy in oncogynecology].
    Nechaeva ID; Kotova DG
    Vopr Onkol; 1978; 24(3):106-15. PubMed ID: 347710
    [No Abstract]   [Full Text] [Related]  

  • 58. Phase I/II study of intraperitoneal iproplatin in patients with minimal residual disease following platinum-based systemic therapy for epithelial ovarian carcinoma.
    Murphy D; Lind MJ; Prendiville J; Renninson J; Smith DR; Thompson G; Ranson M; Crowther D
    Eur J Cancer; 1992; 28A(4-5):870-2. PubMed ID: 1524912
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Early clinical studies with cis-diammine-1,1-cyclobutane dicarboxylate platinum II.
    Calvert AH; Harland SJ; Newell DR; Siddik ZH; Jones AC; McElwain TJ; Raju S; Wiltshaw E; Smith IE; Baker JM; Peckham MJ; Harrap KR
    Cancer Chemother Pharmacol; 1982; 9(3):140-7. PubMed ID: 6761010
    [TBL] [Abstract][Full Text] [Related]  

  • 60. High-dose epirubicin in platinum-pretreated patients with ovarian carcinoma: the EORTC-GCCG experience.
    Vermorken JB; Kobierska A; van der Burg ME; Chevallier B; Zanaboni F; ten Bokkel Huinink WW; Forni M; Pawinski A; van der Putten E; Bolis G
    Eur J Gynaecol Oncol; 1995; 16(6):433-8. PubMed ID: 8536757
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.